Yüklüyor......
Pazopanib in the management of advanced soft tissue sarcomas
Therapy of soft tissue sarcomas represents an area of significant unmet need in oncology. Angiogenesis has been explored as a potential target both preclinically and clinically, with suggestions of activity. Pazopanib is a multitargeted tyrosine kinase inhibitor with prominent antiangiogenic effects...
Kaydedildi:
| Yayımlandı: | Ther Clin Risk Manag |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907704/ https://ncbi.nlm.nih.gov/pubmed/27354810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S84792 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|